Organogenesis Holding (NASDAQ: ORGO) reported Q1 EPS of ($0.02), in-line with the analyst estimate of ($0.02). Revenue for the quarter came in at $107.6 million versus the consensus estimate of $95.52 million.

GUIDANCE:

Organogenesis Holding sees FY2023 revenue of $454-466 million, versus the consensus of $454.8 million.

For earnings history and earnings-related data on Organogenesis Holding (ORGO) click here.